Category Archives: 2016

Two-drug combination boosts survival in patients with metastatic, hormone-sensitive prostate cancer

Patients with newly diagnosed metastatic, hormone-sensitive prostate cancer gained a dramatic survival benefit with simultaneous initiation of two drugs, rather than delaying the second drug until the cancer began to worsen, according to results of a clinical trial recently published more »

Posted in 2016 | Leave a comment

An Excellent Review of Current Imaging and Positron Emission Tomography (PET) Scanning and Their Use in Managing Recurrent and Advanced Disease

This website initially posted a review of positron emission tomography (PET) scanning on March 9th, 2015. More recently, the Prostate Cancer Research Institute (PCRI) November Insights contained an updated and very informative review of the latest PET imaging techniques for more »

Posted in 2016 | 1 Comment

How to Find an Expert Prostate Surgeon

Radical prostatectomy can be a very difficult operation. The very best urological surgeons specialize in the prostate gland. They do a lot of these procedures annually. How do you find the right surgeon? The Prostate Cancer Foundation has published a more »

Posted in 2016 | 1 Comment

The Trap of Discouragement

Do you ever feel as if you are stuck in discouragement? Do you feel that you are facing a condition (such as prostate cancer) alone and that God Himself and family or friends truly do not understand your situation? If more »

Posted in 2016 | Leave a comment

Alcohol May Raise the Risk of Prostate Cancer

An analysis by Canadian and Australian scientists of 27 previous studies led them to conclude that there is a significant association between alcohol use and prostate cancer risk. The more men drink, the greater the risk. Even low levels of more »

Posted in 2016 | Leave a comment

The Four Stages of Prostate Cancer

When you’re diagnosed with prostate cancer, the doctor will determine how far the disease has progressed and tell you what stage the cancer is in. The staging shows how the tumor has grown and if the cancer has spread to more »

Posted in 2016 | Leave a comment

Two New DNA Cancer Vaccines in Phase 1 and Phase 2 Clinical Trials

Madison Vaccines Incorporated (MVI, see the linked news release), has begun a Phase 1 clinical trial for MVI-118 (pTVG-AR) in men with metastatic prostate cancer who are initiating androgen deprivation (hormonal) therapy (ADT). MVI-118 targets the human androgen receptor, the more »

Posted in 2016 | Leave a comment

Hormonal (Testosterone Lowering) Therapy (ADT) Linked to Increased Dementia Risk for Prostate Cancer Patients.

It isn’t often that a research finding appears in 4-5 e mail or other  publications but such is the case herein.  Researchers at Stanford University School of Medicine published a study entitled “Association Between Androgen Deprivation Therapy and the Risk more »

Posted in 2016 | Leave a comment

Monitoring, Not Treatment, May be Better for Very Low-Risk Prostate Cancer Patients

In a study published online on Oct. 20th in the Journal of the American Medical Association (JAMA) Oncology, more than 90 percent of men in Sweden who have very low-risk prostate cancer choose close monitoring rather than immediate treatment — more »

Posted in 2016 | Leave a comment

Radiation Therapy Improves Survival Over Hormone Therapy (ADT) Alone in Metastatic Prostate Cancer

A large database analysis showed that the addition of external beam radiotherapy (RT) to androgen deprivation therapy (ADT) significantly improves overall survival (OS) in men with metastatic prostate cancer. “As advances in systemic therapy for metastatic prostate cancer have improved more »

Posted in 2016 | Leave a comment